RNO.AX
Price:
$0.04
Market Cap:
$11.47M
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and ...[Read more]
Industry
Medical - Devices
IPO Date
2007-09-21
Stock Exchange
ASX
Ticker
RNO.AX
According to Rhinomed Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0. This represents a change of -100.00% compared to the average of 0.69 of the last 4 quarters.
The mean historical Current Ratio of Rhinomed Limited over the last ten years is 2.80. The current 0 Current Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), RNO.AX's Current Ratio was at its highest in in the June 2009 quarter at 10.58. The Current Ratio was at its lowest in in the September 2009 quarter at 0.
Average
2.80
Median
2.44
Minimum
0.27
Maximum
6.74
Discovering the peaks and valleys of Rhinomed Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.31%
Maximum Annual Current Ratio = 6.74
Minimum Annual Increase = -84.39%
Minimum Annual Current Ratio = 0.27
Year | Current Ratio | Change |
---|---|---|
2023 | 0.27 | -84.39% |
2022 | 1.73 | -36.25% |
2021 | 2.71 | -59.80% |
2020 | 6.74 | 210.31% |
2019 | 2.17 | -3.12% |
2018 | 2.24 | -15.19% |
2017 | 2.65 | -32.45% |
2016 | 3.92 | 88.58% |
2015 | 2.08 | -40.31% |
2014 | 3.48 | 140.56% |
The current Current Ratio of Rhinomed Limited (RNO.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.57
5-year avg
2.73
10-year avg
2.80
Rhinomed Limited’s Current Ratio is less than IDT Australia Limited (1.34), less than Botanix Pharmaceuticals Limited (22.21), less than Incannex Healthcare Limited (2.88), less than Zelira Therapeutics Limited (0.60), less than Stemcell United Limited (2.11),
Company | Current Ratio | Market cap |
---|---|---|
1.34 | $46.49M | |
22.21 | $863.37M | |
2.88 | $65.07M | |
0.60 | $7.15M | |
2.11 | $3.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhinomed Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rhinomed Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Rhinomed Limited's Current Ratio?
How is the Current Ratio calculated for Rhinomed Limited (RNO.AX)?
What is the highest Current Ratio for Rhinomed Limited (RNO.AX)?
What is the 3-year average Current Ratio for Rhinomed Limited (RNO.AX)?
What is the 5-year average Current Ratio for Rhinomed Limited (RNO.AX)?
How does the current Current Ratio for Rhinomed Limited (RNO.AX) compare to its historical average?